Sign in
4

Changes in Ownership

Spyre Therapeutics, Inc. Filed Acc 0001209191-20-035506

Options or other derivatives

  • Director acquired 28,100 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Bruhn Suzanne Louise · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-06-08 Grant or award : show line 1 in the form Director Stock Option (right to buy) +28,100 28,100 D
Loading xslF345X03/doc4.xml…